Xiaobo Cui

1.4k total citations
49 papers, 864 citations indexed

About

Xiaobo Cui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaobo Cui has authored 49 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Xiaobo Cui's work include Cancer-related gene regulation (8 papers), RNA modifications and cancer (8 papers) and Epigenetics and DNA Methylation (6 papers). Xiaobo Cui is often cited by papers focused on Cancer-related gene regulation (8 papers), RNA modifications and cancer (8 papers) and Epigenetics and DNA Methylation (6 papers). Xiaobo Cui collaborates with scholars based in China, United States and Canada. Xiaobo Cui's co-authors include Jingxuan Yang, Xianjun Yu, Songbin Fu, Yu‐Qing Zhang, Huaqing Yan, Min Li, Xiangning Meng, Jiang Long, Liqi Zhang and Martín E. Fernández-Zapico and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Scientific Reports.

In The Last Decade

Xiaobo Cui

48 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo Cui China 18 574 319 210 94 66 49 864
Kyung Hee Koo South Korea 9 487 0.8× 245 0.8× 194 0.9× 42 0.4× 84 1.3× 11 760
Tasneem Motiwala United States 17 662 1.2× 209 0.7× 148 0.7× 56 0.6× 63 1.0× 21 865
Laura Antonucci Italy 14 446 0.8× 120 0.4× 209 1.0× 61 0.6× 46 0.7× 21 746
Lucia D’Antona Italy 17 436 0.8× 139 0.4× 108 0.5× 44 0.5× 47 0.7× 30 748
Chian‐Feng Chen Taiwan 18 533 0.9× 240 0.8× 150 0.7× 22 0.2× 87 1.3× 32 830
Chie Nakashima Japan 17 348 0.6× 215 0.7× 143 0.7× 29 0.3× 81 1.2× 43 607
Fei Yue China 14 649 1.1× 140 0.4× 227 1.1× 100 1.1× 103 1.6× 32 972
Céline Levalois France 14 577 1.0× 202 0.6× 258 1.2× 40 0.4× 93 1.4× 18 878
Guanhong Luo China 15 608 1.1× 383 1.2× 142 0.7× 34 0.4× 41 0.6× 23 764
Honglin Song United Kingdom 24 904 1.6× 315 1.0× 441 2.1× 60 0.6× 63 1.0× 41 1.6k

Countries citing papers authored by Xiaobo Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Cui more than expected).

Fields of papers citing papers by Xiaobo Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Cui. The network helps show where Xiaobo Cui may publish in the future.

Co-authorship network of co-authors of Xiaobo Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Cui. A scholar is included among the top collaborators of Xiaobo Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Cui. Xiaobo Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dongmei, Meiqi Zhao, Ping Jiang, et al.. (2025). RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis. Journal of Translational Medicine. 23(1). 244–244. 1 indexed citations
2.
Meng, Xiangning, Yanghe Liu, Xu Wang, et al.. (2024). Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance. British Journal of Cancer. 130(11). 1819–1827. 3 indexed citations
3.
He, S., Xiaoxiao Ni, Xiaofei Wang, et al.. (2024). Research and application of low oil-water ratio organoclay-free oil-based drilling fluid technology. SHILAP Revista de lepidopterología. 560. 1016–1016. 1 indexed citations
4.
Li, Jiaqi, et al.. (2024). Expression, DNA methylation pattern and transcription factor EPB41L3 in gastric cancer: a study of 262 cases. Cell Communication and Signaling. 22(1). 470–470. 1 indexed citations
5.
Hao, Siyu, et al.. (2023). Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer. Journal of Cellular and Molecular Medicine. 27(16). 2424–2436. 4 indexed citations
6.
Yan, Huaqing, et al.. (2022). From Cognitive MR‐Targeted Fusion Prostate Biopsy to Radical Prostatectomy: Incidence and Predictors of Gleason Grade Group Upgrading in a Chinese Cohort. BioMed Research International. 2022(1). 7944342–7944342. 3 indexed citations
7.
Yang, Ting, Jinfeng Zhang, Dong Wang, et al.. (2022). The promoter methylation drives down-regulation mode of HIC1 in gastric cancer, its molecular characteristics and downstream functional pathways. Gene. 824. 146380–146380. 3 indexed citations
8.
Yan, Huaqing, et al.. (2021). Fruit and Vegetable Consumption and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Nutrition and Cancer. 74(4). 1235–1242. 6 indexed citations
9.
Liu, Mingyang, Yu‐Qing Zhang, Jingxuan Yang, et al.. (2019). ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 158(3). 679–692.e1. 109 indexed citations
10.
Zhang, Huishu, Wei Gao, Ying Song, et al.. (2018). Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate‐resistant colon cancer cells. International Journal of Cancer. 144(5). 1037–1048. 49 indexed citations
11.
Cui, Xiaobo, et al.. (2018). Public mobilisation in implementation of smoke-free Beijing: a social media complaint platform. Tobacco Control. 28(6). 705–711. 7 indexed citations
12.
Liu, Xu, et al.. (2016). Screening of Bioactive Ingredients in Ligusticum Chuanxiong Hort for Protection against Myocardial Ischemia. Cellular Physiology and Biochemistry. 40(3-4). 770–780. 28 indexed citations
13.
Cui, Xiaobo, et al.. (2016). Elevated IQGAP1 and CDC42 levels correlate with tumor malignancy of human glioma. Oncology Reports. 37(2). 768–776. 12 indexed citations
14.
Luo, Guopei, Jiang Long, Xiaobo Cui, et al.. (2013). Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. International Journal of Oncology. 42(3). 979–984. 34 indexed citations
15.
Liu, C., Cheng He, Si Shi, et al.. (2013). MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3. Current Molecular Medicine. 13(4). 467–478. 50 indexed citations
16.
Xu, Jin, Wenwei Zhu, Xiaobo Cui, et al.. (2013). Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. International Journal of Oncology. 42(6). 2046–2052. 24 indexed citations
17.
Long, Jiang, Guopei Luo, Chen Liu, et al.. (2012). Development of a unique mouse model for pancreatic cancer lymphatic metastasis. International Journal of Oncology. 41(5). 1662–1668. 19 indexed citations
18.
Yu, Jingcui, Peng Liu, Xiaobo Cui, et al.. (2011). Identification of Novel Subregions of LOH in Gastric Cancer and Analysis of the HIC1 and TOB1 Tumor Suppressor Genes in These Subregions. Molecules and Cells. 32(1). 47–56. 24 indexed citations
19.
Meng, Xiangning, Yan Jin, Jing Bai, et al.. (2008). Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biology International. 32(6). 663–670. 46 indexed citations
20.
Ma, Linlin, Yali Xue, Yan Liu, et al.. (2006). Polymorphism study of seven SNPs at ADH genes in 15 Chinese populations. Hereditas. 142(2005). 103–111. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026